During the weeklong stay by the…
During the weeklong stay by the Supreme Court to temporarily [...]
Explore how targeted protein…
Explore how targeted protein degradation is reshaping drug discovery, enabling [...]
Gilead raised its previous…
Gilead raised its previous guidance of $800 million in revenues [...]
With an eye on the lucrative U.S….
With an eye on the lucrative U.S. market, Italy’s Angelini [...]
After a surprise rejection in…
After a surprise rejection in January, the FDA has agreed [...]
With a better-than-expected first…
With a better-than-expected first quarter in the books, Pfizer—continuing to [...]
Novartis is continuing its…
Novartis is continuing its multiyear overhaul with new plans to [...]
The German vaccine maker plans to…
The German vaccine maker plans to wind down operations at [...]
The U.S. Supreme Court has…
The U.S. Supreme Court has temporarily reinstated online access to [...]
The company chalks up a financial…
The company chalks up a financial impact of about 150 [...]